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Abstract We first aimed to generate transformed cell
lines from a human induced pluripotent stem cell (hiPSC)-
teratoma, and then examined the tumorigenic risks of the
differentiated cells from hiPSC explant, because hiPSC-
derivatives give rise to tumors in immune-deficient mice
when transplanted. The colonies isolated from sparse cul-
tures of hiPSC-teratoma cells expressed NANOG and
OCT3/4 strongly, and telomerase reverse transcriptase
(TERT) weakly. However, soft agar assay demonstrated
that only one of them generated colonies in the gel, though
hiPSCs, hTERT-transfected immortal cells, and its onco-
gene-transfected cells did not form any colonies. Further-
more, none of colonies isolated from the soft agar gel on
primary culture (passage 0) of teratoma cells, expressed
NANOG and OCT3/4 in the expanded cultures. The second
soft agar assay on the colony-derived cells was unexpect-
edly negative. The cumulative growth curve, telomere
shortening, and senescence-associated b-galactosidase (SA
b-gal) staining confirmed the mortality of these cells,
suggesting their reversible transformation. By using med-
ium for embryonic stem cell (ESC medium) after MCDB
131 (MCDB) medium, the differentiated culture cells
derived from hiPSC-teratoma converted into the cells
expressing undifferentiated marker proteins, which lost
afterwords even in ESC medium with feeder SNL76/7. The
reversibility of transformation and de-differentiation sug-
gest that tumorigenic risks of differentiated cells arise
when they are exposed to suitable niches in vivo. Thus,
removal of only the undifferentiated cells from iPSC-
derivatives before transplantation does not solve the
problem. Elucidation of mechanisms of reversibility and
control of epigenetic changes is discussed as a safety bot-
tleneck for hiPSC therapy.
Keywords hiPSC therapy  Tumor risk  Transformation 
De-differentiation  Reprogramming
Introduction
One of the criteria for pluripotency of hiPSC lines is their
ability to form teratomas in immune-deficient mice [1, 2].
Thus, the safety of hiPSC lines produced by genetic
introduction remains a great concern for their use in
regenerative medicine [3]. Because now a pilot study to
assess the safety and feasibility of the transplantation of
iPSC-derived retinal pigment epithelium cell sheets in
patients with exudative age-related macular degeneration
has started in Japan [4], every probable tumorigenic risk
should be thoroughly checked in advance.
Since tumors arise from transformed cells or remaining
undifferentiated cells in iPSC-derivatives [5, 6], works to
avoid the risk of tumorigenesis were focused on develop-
ments of sensitive methods to detect [7] and removal of
remaining undifferentiated cells from iPSC-derivatives
before their transplantation [8]. In transplants of secondary
neurospheres generated from tail tip fibroblast-derived
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development of tumors. The reason was not explained well
[5]. Our finding on formation of various malignant tumors
due to contaminated mouse feeder cells in the explant
might explain some of the reasons [9]. However, unknown
mechanisms seem to exist in emergence of transformed
cells from iPSC derivatives. Our recent study [10] on re-
emergence of undifferentiated cells from hiPSC-derivatives
prompted us to examine risks of transformation and de-
differentiation of the differentiated cells. Further, a series
of studies on cellular aging [11], immortalization [12], de-
differentiation [10], and reprogramming [13] of human
fibroblast TIG-1, urged us to isolate transformed cells from
TIG-1 iPSC-teratomas and to disclose novel tumor risks of
hiPSC-derivatives.
The anchorage-independent colony forming ability of
cells is recognized as an indication of malignant transfor-
mation with metastatic potential [14]. Thus, we were also
interested in isolating transformed cells from a hiPSC-ter-
atoma by colony formation in a soft agar gel system.
In this paper, we aimed to generate transformed or de-
differentiated cells from hiPSC-derivatives and to prove
their reversibility.
The results demonstrate that removal of only the
undifferentiated cells from hiPSC-derivatives before
transplantation does not solve the problem. Mechanisms of
the reversibility and control of epigenetic changes are
discussed for prospect in hiPSC therapy.
Materials and methods
Cell lines and cultures
Normal human diploid fetal lung fibroblasts (TIG-1) [15],
their telomerase reverse transcriptase (hTERT)-transfected
immortal cell lines (IMT-1, -2, and -3) [12], their onco-
gene-transfected cell lines (IMT-1/RAS was generated by
transfecting K-RAS12V into IMT-1, and IMT-2/BBR was
established by transfecting BMI-1, BCL-2, and K-RAS12V
into IMT-2), a cancer cell line (HeLa), and a feeder cell
line (SNL76/7) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen) supplemented with
10 % fetal bovine serum (FBS, Gibco). We cultured hiPSC
lines (K1, K4, K12, K13, and K17) in human ESC medium
with SNL76/7 feeder as described previously [13]. For
culture of hiPSC-teratoma-derived cells (K4te, K12te,
K13te, and K17te from respective iPSC lines) and their
clones, we used MCDB 131 (Sigma) (MCDB) supple-
mented with 10 % FBS. We cultured soft agar-derived
clones of K12te (K12te-sa clone1-4) in DMEM or MCDB
containing 10 % FBS. To examine the change in the
expression of undifferentiation marker proteins, we cul-
tured K17te for 21 days in human ESC medium after
MCDB medium. Population doubling level (PDL) was
roughly estimated by assuming that PDL achieved 20 at
cell number of 106 from single cell colony.
hiPSC generation
Plasmid DNAs of pCX-OKS-2A and pCX-c-Myc, which
was used to generate mouse iPSC by Okita et al. [16], were
cut with the restriction enzyme PshBI. A mixtuire of equal
amounts of two plasmids at mole basis was nucleofected to
1 9 106 cells of TIG-1 at 17 PDL with pmax-green fluo-
rescent protein (GFP) plasmid by using Nucleofector
(Lonza) apparatus. Nucleofected cells were seeded in dishes
and cultured with DMEM containing 10 % FBS. At day 7,
confluent cells of each dish were trypsinized and transferred
to new dishes with SNL feeder cells using human ESC
medium. Valproic acid was added at the concentration of
1 mM. At day 23 and 33, ESC-like colonies were picked by
ring cloning using a dissociation solution (ReproCELL,
Japan). Colonies were washed with human ESC medium by
centrifugation and seeded to expand, and finally stored at
-150 C using a freezing reagent (ReproCELL, Japan).
Teratoma formation and isolation
of teratoma-derived cells
We generated hiPSCs teratomas as previously described
[13]. The formed tumor was fixed with 4 %
paraformaldehyde solution to examine histopathology by
staining with hematoxylin and eosin at Sapporo General
Pathology Laboratory Co., Ltd. (Sapporo, Japan). Another
part of the fresh tumor was subjected for cell isolation as
described before [10]. We cultured some of the isolated
cells (K12te, K17te) at an extremely low density for
2 weeks and then picked the colonies formed from single
cells into dishes as clones and expanded them for further
examination. K12 (passage 0) was prepared by seeding the
isolated cells into dish at high density to examine anchor-
age independent capability at the sixth day of culture.
RNA isolation, reverse transcription,
and polymerase chain reaction (PCR)
We purified the total RNA to perform PCR with an
appropriate primer set and Primestar DNA polymerase
(Takara Bio, Japan) as described previously [10]. The
primer sequences used are given in Table 1.
Isolation of anchorage-independent growing cell
colonies and their cultures
We used trypsin treatment to harvest the cells for the soft
agar assay. In the case of hiPSCs, we added 5 lM the Rho-
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associated protein kinase (ROCK) inhibitor, thiazovivin
(Stemgent), to the cell suspension following the protocol of
the manufacture. We seeded 1.0 9 105 to 1.0 9 106 cells
in 5–8 mL of a 0.33 % upper agar layer on 1.0 % under
agar layer with DMEM containing 10 % FBS. To prevent
the gel from drying, we added an appropriate medium for
each culture to the gel with 1 week interval. After culturing
for 2–4 weeks, we counted the colonies consisting of more
than 100 actively growing cells in the gel as the number of
anchorage-independent colonies. For further experiments,
we picked up the colonies using a tip and expanded them in
separate dishes for culture.
Analysis of telomere length
We isolated genomic DNA from culture cells and tumor
tissues to examine telomere lengths using the TeloTAGGG
telomere length assay kit (Roche, Switzerland) and deter-
mined the mean length of telomere restriction fragment
(TRF) using Telometric 1.2 as described before [12].
Detection of senescence-associated b-galactosidase
activity
The growth-arrested cells were fixed, washed, and incu-
bated with staining solution as described previously [12].
We detected the stained blue cells for senescence-associ-
ated b-galactosidase (SA b-Gal) activity and counted the
percentage of the stained cells.
Immunocytochemistry and quantification
of undifferentiation marker proteins
We performed immunocytochemistry of OCT4, NANOG,
and SSEA4 to quantify the fluorescent area for analysis of
significant difference. Their primary antibodies were
detected by Alexa594, Alexa488, and Alexa555, respec-
tively. Slides were observed with Axiovert 200 M fluo-
rescence microscope system (Carl Zeiss, Germany) after
staining. Details are described previously [10].
Results and discussion
Isolation of clonal colonies from the hiPSC-teratoma
and their transformed characteristics
Among 22 hiPSC lines (K1–K22) [13] generated from
TIG-1, K12 and K17 hiPSC lines were selected to generate
teratoma in a severe combined immunodeficient mouse.
Their histopathological analysis demonstrated the presence
of glandular epithelium, connective tissue, and blood ves-
sels in K12 teratoma (Fig. 1a) and of glandular epithelium,
cartilage like tissue, and blood vessels in K17 teratoma
(Fig. 4a). First, we isolated cells from K12 hiPSC-teratoma
(K12te) and cultured them at a very low density for single
cell colonies. We isolated rapidly growing colonies with
different morphologies (Fig. 1b, c) from the culture and
expanded them in separate dishes for further analysis of
gene expression. We found that any clones did not express
the neomycin resistant gene (Neor) (Fig. 1e), confirming
that the cells were derived from hiPSCs but not mouse
feeder cells, as aforementioned [9]. The fibroblast secretary
protein-1 (FSP-1) gene was expressed in all the clones,
suggesting that they were not epithelial cells. Among
endothelial cell marker genes, CD31 (PECOM-1) was
expressed in clones 1, 2, 4, and 5, and vascular endothelial
growth factor receptor 2 (VEGFR-2) was not expressed in
any clones. However, CD34, a marker of the progenitors of
vascular cells, was expressed in all clones. Thus, it seemed
that these cells were progenitors of the vascular tube at
different stages of differentiation. The analyses also
showed that cell cycle regulatory genes or tumor
Fig. 1 Isolation of cloned cells from hiPSC-teratoma, gene expres-
sion, and transformation. a Histopathology of K12 teratoma. b Clone
2 and c clone 4 are colonies from the teratoma. e Gene expression
analyses of growth regulating genes and differentiation genes.
d Colonies in the soft agar gel were formed only from clone 4.
Clone 1, 2, 3, 4, 5, 6, and 7 in this paper corresponds to L2, L4, L9,
L11, L12, R4, and R7, respectively in our previous paper [10], from
which expression of GAPDH* was referred. The bars indicate
100 lm (a, b, c) or 200 lm (d)
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suppressor genes (RB, P53, P21, and P16) were expressed
in all the clones. Among reprogramming genes, NANOG
was expressed in clones 1, 2, and 4; OCT3/4 in clones 2, 4,
and 5; and c-MYC and KLF4 in every clone as shown
previously [10].
Then, we selected clone 2 (Fig. 1b) and clone 4
(Fig. 1c) to isolate transformed cell lines, because they
expressed four reprogramming genes and hTERT. The soft
agar assay demonstrated that only clone 4 generated
approximately 100 colonies in the gel (one of the single
colonies is shown in Fig. 1d). And, clone 2 did not generate
any colonies (K12te-clone 2 in Table 2), even though they
expressed reprogramming genes (strongly) and hTERT
(slightly) like undifferentiated hiPSCs did. This suggests
that the remaining undifferentiated cells are not necessarily
transformed cells. Because many large colonies were
formed in the gel from clone 4, we isolated colonies into
culture for analysis of transformed nature. However, the
isolated cells lost their growth capability after 10–20 PDLs,
suggesting a reversible nature of their transformation.
Transformed cells from a primary culture
of hiPSC-teratoma and their reversible nature
Because rapidly growing colony cells at an extremely low-
density culture exhibited a transient nature of transforma-
tion irrespective of their expression of undifferentiated cell
markers, we questioned if transit transformation happened
during sub-cultivation. Therefore, we checked existence of
transformed cells in primary cells (passage 0) of K12te.
Soft agar assay of the cells (K12te passage 0 in Table 2)
demonstrated formation of 18 big colonies at 4 weeks. We
picked up colonies into separate dishes for further culture
and established 8 clones (K12te-sa clones 1–8). Four
colonies (clones 1, 2, 3, and 4) in the gel (Fig. 2a, c, e, g,
respectively) showed some differences in the morphology
(Fig. 2b, d, f, h, respectively). Gene expression analysis of
three clones (clones 1, 2, and 3) demonstrated that they did
not express reprogramming genes (NANOG, OCT3/4, and
SOX2) in contrast to their high expression in the original
K12 iPSC (Fig. 2j). Furthermore, undifferentiated cell
marker genes, REX1 and hTERT, were not expressed in
these clones. These findings indicate that transformed cells
exist in a teratoma, though they are not derived from
remaining undifferentiated cells.
Anchorage-independent growth capability
of various human cell lines in a soft agar gel
We considered that soft agar gel colony formation of iPSC-
teratoma-derived cells was an indication of the generation
of malignantly transformed cells, since anchorage-inde-
pendent cell growth signature identifies tumors with meta-
static potential [14]. However, the present findings that the
Table 2 Colony formation of human cell lines in a soft agar gel
Characteristics Transgenes Names of cell lines Colony formation in soft agar gel
Normal cell No TIG-1 nda
Cancer cell No HeLa ?
Immortal cell hTERT IMT-1 -
IMT-2 -
IMT-3 -
Oncogene-transfected cell hTERT, K-RAS12V IMT-1/RAS -
hTERT, BMI-1, BCL-2, K-RAS12V IMT-2/BBR -
hiPSC Oct4, Sox2, Klf4, c-Myc K1 -
K4 -
K12 -
Teratoma-derived cell Oct4, Sox2, Klf4, c-Myc K4te (15 PDL) -
K13te (4 PDL) -
K12te clone 2 (26 PDL) -
K12te clone 4 (27 PDL) ?b
K12te (Passage 0) ?c
Cell from colonyc Oct4, Sox2, Klf4, c-Myc K12te-sa clone 1 (26 PDL) -
K12te-sa clone 1 (57 PDL) -
Anchorage-independent growth capability was positive in K12te at passage 0 (c) and K12te clone 4 at 27 PDL (b). Note that the colony formation
of K12te-sa clone 1 (26 and 57 PDL) was negative after expansion from the first gel colony of K12te (passage 0)
PDL population doubling level
a nd not determined, b shown in Fig. 1, c shown in Fig. 2
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transformed cells from hiPSC-teratoma are not remaining
undifferentiated cells, and lost their growth capability after
isolation into culture, prompted us to re-evaluate anchor-
age-independent growth capability by using various human
cell lines that we have established from the same parent cell
line, TIG-1. A positive control of human cancer cell line,
HeLa, formed colonies (over 1000) in gel as expected. As
shown in Table 2, K12 hiPSC-teratoma-derived cells
(K12te) at passage 0, and K12te-clone 4 (at 27 PDL),
generated colonies, though K4te at 15 PDL and K13te at 4
PDL were negative. Furthermore, immortal cell lines (IMT-
1, -2, and -3) and oncogene-transfected cell lines (IMT-1/
RAS and IMT-2/BBR) did not form any colonies. Thus, the
colony-forming ability in a soft agar gel shown here present
resemblance to malignant transformation rather than just
immortalization as reported [14]. In addition, it is note-
worthy that hiPSC lines (K1, K4, and K12) did not generate
any colonies even in the presence of a ROCK inhibitor
(used to promote survival of isolated single hiPSC). This is
in accordance with a report that a soft agar colony formation
assay was unable to detect hiPSCs in the presence of a
ROCK inhibitor [7]. Furthermore, it is notable that colony
formations of the second assay were unexpectedly negative
on K12te-sa clone 1 (at 26 and 57 PDL) when subjected for
the assay, after expansion of the soft agar colony derived
from K12te (passage 0). Thus, it is noteworthy that their
transformed property is not robust but reversible.
Gene expression and replicative senescence
of transformed cells
We expanded three clones (K12te-sa clones 1, 2, and 3) from
the transformed cells with anchorage-independent growth
ability (K12te passage 0) for gene expression analysis
comparing with parent K12 hiPSC (Fig. 2j). They expressed
oncogenes (RAS, RAF-1, MDM2, and BMI1) and anti-
oncogenes (RB1, P53, P21, P16, and P14) at similar levels.
Expression of BCL2, an oncogene with anti-apoptotic
action, was high in K12te-sa clone 1, but low in the other 2
clones. A marker of endothelial cells, CD31 and a marker of
its progenitor, CD34, were highly expressed only in clone 1.
Because we found the second soft agar assay of clone 1
was negative (K12te-sa clone 1 in Table 2) as mentioned
above section, irrespective of positive result in the first
assay (K12te passage 0 in Table 2), we performed a long-
term subcultivation of clones 1, 3, and 4 to determine if
they were mortal or immortal. A cumulative growth curve
(Fig. 3a) demonstrates that all of them were mortal (clone
1 ceased to grow at 71 PDL, clone 3 at 46 PDL, and clone 4
at 28 PDL). Then, we analyzed changes in the telomere
length during their subcultivation (Fig. 3b). The average
TRF length in K12 hiPSCs and K12 teratoma were 8.0 and
10.6 kbp, respectively. It is noteworthy that the repro-
grammed cells and the teratoma cells had longer telomeres
than did parent young TIG-1 cells (6.0 kbp). In addition, it
is apparent that the telomeres of each clone at 4 PDL
became shortened at their late passages (K12te-sa clone 1,
from 9.4 to 5.8 at 46 PDL; clone 3, from 9.1 to 5.1 at 30
PDL; and clone 4, from 8.4 to 6.3 at 31 PDL in Fig. 3b)
indicating their proliferative senescence. Next, we exam-
ined SA b-Gal staining at the terminal stage of cell culture.
Their senescence was confirmed by 94.7 % blue cell
staining in clone 1 and 96.2 % in clone 3 (Fig. 3c, d,
respectively). Loss of anchorage-independent growth
capability during expansion culture would be due to pro-
liferative senescence, though a possibility of terminal dif-
ferentiation may not be excluded. Thus, we confirmed a
reversible nature of the transformation of these cells.
Clonal differentiated cells from hiPSC-teratoma
and the reversible nature of de-differentiation
Because we knew a reversible nature of the transformation
(Figs. 1, 2, 3), we speculated that similar reversibility
Fig. 2 Generation of colonies using primary cells from hiPSC-
teratoma and reversible transformation. The soft agar colony (a, c, e,
and g) and their isolated culture cells (b, d, f, and h) are shown by
phase- contrast microscopy; K12te-sa clone 1 (a, b), clone 2 (c, d),
clone 3 (e, f), and clone 4 (g, h), respectively. i K12 hiPSC did not
generate any colonies. j Note that any cloned cell line did not express
the undifferentiated genes. The bars indicate 100 lm
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might occur in the differentiation of cells from the ter-
atoma. Thus, we performed extremely low density-cultures
of K17hiPSC-teratoma-derived cells (K17te) (Fig. 4a for
histopathological staining) with MCDB medium and
obtained a several growing colonies in dishes. We isolated
and expanded them as clones revealing epithelial-like
morphology (Fig. 4b, panel of MCDB and Phase-contrast).
After seeding them in five 3-cm dishes, we changed the
medium from MCDB to ESC, which has been previously
used for proper hiPSC culture. However, ESC medium
causes damage to differentiated cells. Immunocytochemi-
cal analyses demonstrated that the undifferentiated cell
marker proteins, SSEA4, OCT4, and NANOG did not exist
during the culture in MCDB medium, but appeared at the
third day after medium change to ESC medium and
increased in their cell numbers with successive days of
culture (Fig. 4b). We observed damages and loss of the
differentiated cells under phase-contrast microscopy.
Because the culture was not supported by a feeder cell
layer, the remaining undifferentiated cells, if any, would
not self-replicate. Thus, an overwhelming number of cells
with undifferentiation marker proteins which increased in
number after medium change, must be de-differentiated
cells which bear resemblance to hiPSC-like cells. Quanti-
tative analyses on areas of SSEA4, OCT4, and NANOG
staining showed that quantities of each marker proteins of
de-differentiated cells reached to the level of hiPSC
(Fig. 4c). Thus, we assume that differentiated cells
converted into de-differentiated cells by unknown factors
during culture at a severe condition with ESC medium.
However, their morphological features were not similar to
those of true hiPSCs. Then, we isolated the de-differenti-
ated cell colonies to culture with a feeder layer in ESC
medium which have been used for proliferation of hiPSCs.
All of our trials to obtain stable hiPSC-like lines have
failed, suggesting the transit conversion of de-differenti-
ated state. Thus, we confirmed the reversible nature of both
differentiation and de-differentiation.
New insights into tumorigenic risks and possible
mechanisms of reversibility in transformation
and de-differentiation
Reversibility of de-differenation and transformation was
proved in the teratoma cells from hiPSC lines generated
with inserted genes. It leads us to new insights into
tumorigenic risks of hiPSC derivatives transplanted. First,
removal of only the undifferentiated cells from iPSC
derivatives before transplantation, as focused in previous
works [7, 8], does not solve the problem.
Second, it is required to perform extensive studies on
unsolved questions to elucidate molecular mechanisms of
the reversibility.
The hiPSCs in this paper were generated by introduction
of CAG promoter-drive OSK2A and CAG promoter-drive
c-Myc plasmids as shown [16]. Thus, a possible expression
Fig. 3 Cumulative growth curve, telomere length, and SA b-Gal
staining. a K12te-sa clone 1 (filled circle), clone 3 (filled square), and
clone 4 (filled traingle) lost their growth capability. b Telomere
restriction fragment (TRF) was elongated in hiPSC and the teratoma
tissue, from TRF in parent cell line, TIG-1, and it decreased at late
passages in each clone. Percentage of SA b-Gal staining in clone 1
(c) and clone 3 (d) was about 95 %. Thus, replicative senescence of
colony-derived cells from the soft agar gel was confirmed. *TRF of
TIG-1 was referred from our previous paper [12]
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of these exogenous genes might cause the reversibility in
the cells. However, we should test the hypothesis of the
reversibility using hiPSC lines generated without viral
vectors [16] or by direct introduction of reprogramming
proteins [17], which have no inserted genes, and also using
embryonic stem cell (ESC) lines generated from inner cell
mass.
Each line of ESC or iPSC holds some donor cell char-
acteristics and thereby they are not identical in ability to
differentiate and in safety for cell therapy. Furthermore,
derivatives of even germ-line-competent iPSCs lines
allowed the generation of residual undifferentiated cells in
adult mice [18]. This suggests that undifferentiated iPSC-
like cells could not be eliminated by extended cell
differentiation.
Process of iPSC generation is stepwise resetting of
epigenetic landscape as reported [19]. Thus, we suppose
that chromatin modifications in iPSCc have become more
susceptive to environmental changes. The most important
chromatin modification is methylation or de-methylation of
DNA and histones as well as levels of acetylation and
citrullination of histones, which might be involved in
reversibility of transformation and de-differentiation in
hiPSC-derivative cells.
As for unknown factors in ESC medium to convert cells
into de-differentiated cells, constituents in ESC medium
such as FGF-2 and 2-mercapto-ethanol as well as chemical
agents known to alter chromatin conformations are worth
testing their effects on emergence of transformed cells or
de-differentiated cells.
Finally, we should look beyond just improving the
reprogramming process [20] or removing only remaining
undifferentiated cells in advance [3]. The epigenomes of
both pluripotent cells and differentiated cells are not robust
as expected [19] but flexible with changes of cellular
environments.
Results of further extensive studies on new mechanisms
should be used to remove tumorigenic risks for regenera-
tive therapy with hiPSCs.
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Fig. 4 Histopathology of the
K17 hiPSC-teratoma and
conversion of hiPSC-teratoma-
derived differentiated cells to
the cells with undifferentiation
marker proteins. a The K17
hiPSC line formed a teratoma
with glandular epithelium,
cartilage-like tissue, and
vascular tube. b Immuno-
cytochemical detection of
undifferentiated cell marker
proteins. Clone of K17te was
cultured with MCDB medium
(MCDB) or ESC medium
(ESCM) Phase-contrast images
are shown in panels of Phase-
contrast. c The mean
percentages of fluorescent area
of NANOG, OCT4, and SSEA4,
were determined by analyzing
three photographs for each
sample. *P\ 0.05, statistical
significance from the value at
MCDB
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